Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
53,778,088
-
Share change
-
+50,623,588
-
Total reported value
-
$908,062,778
-
Put/Call ratio
-
62%
-
Price per share
-
$16.82
-
Number of holders
-
82
-
Value change
-
+$853,769,936
-
Number of buys
-
68
-
Number of sells
-
12
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2018
As of 31 Dec 2018,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,778,088 shares.
The largest 10 holders included
UBS Group AG, BANK OF AMERICA CORP /DE/, CITIGROUP INC, GOLDMAN SACHS GROUP INC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, NORTHERN TRUST CORP, Mondrian Investment Partners LTD, CAUSEWAY CAPITAL MANAGEMENT LLC, Parametric Portfolio Associates LLC, and CREDIT SUISSE AG/.
This page lists
82
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.